Nov 13 (Reuters) - Medicenna Therapeutics Corp
* Medicenna reports second quarter fiscal 2018 financial results
* Q2 loss per share C$0.07
* Medicenna Therapeutics Corp - Medicenna ended quarter with a cash balance of $9.5 million
* Medicenna Therapeutics Corp - company has sufficient resources to fund research and development and operations into Q1 of calendar 2019 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.